Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia
Clinical trial NCT00427791 · COMPLETED
Trial details
- NCT number
- NCT00427791
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.